Cutaneous Lupus (DBCOND0037892)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06647069
DR-0201 in Subjects With Autoimmune DiseasesNo drug interventionstreatment1not_yet_recruiting
NCT06599411
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01164917
Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusNo drug interventionstreatment1terminated
NCT03288324
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupustreatment1 / 2completed
NCT02176148
Cutaneous Lupus Medication Experience StudyNot AvailableNot Availableactive_not_recruiting
NCT03639857
Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids AloneNo drug interventionstreatmentNot Availableterminated
NCT00512694
Duke Lupus RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00513591
Duke Autoimmunity in Pregnancy RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT03276923
Maternal Autoimmune Disease Research Alliance (MADRA) RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01408199
Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupustreatment4completed
NCT03122431
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseasestreatment4completed
NCT01389895
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusNo drug interventionstreatment1terminated
NCT06506214
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous LupusNo drug interventionsNot AvailableNot Availablerecruiting
NCT05048238
Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupustreatment1completed